| AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) (NCT07285694) | Arsenal Biosciences, Inc. | 2026-01-09 |
| Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors (NCT07349537) | Revolution Medicines, Inc. | 2026-01-08 |
| A Clinical Study of RSS0343 in Healthy Subjects (NCT07289464) | Reistone Biopharma Company Limited | 2026-01-08 |
| Phase 1 Study of SBS-147 in Healthy Adults (NCT07335913) | Sparian Biosciences, Inc | 2026-01-08 |
| A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors (NCT07131202) | Suzhou Forlong Biotechnology Co., Ltd | 2026-01-08 |
| An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors (NCT07359066) | Shanghai SciBrunch Therapeutics Co., Ltd. | 2026-01-08 |
| HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors (NCT07296341) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2026-01-08 |
| A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) (NCT07275788) | Regend Therapeutics | 2026-01-08 |
| Nicotine Pouch Pharmacokinetics Abuse Liability (NCT07476144) | JT International SA | 2026-01-08 |
| Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas (NCT07456878) | Mayo Clinic | 2026-01-08 |
| A Study to Find a Suitable Dose of Exl-111 for Further Research (NCT07356713) | Excellergy Inc. | 2026-01-08 |
| A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies (NCT07195916) | Incyte Corporation | 2026-01-08 |
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD (NCT07158775) | Bionic Sight LLC | 2026-01-08 |
| Retifanlimab and Ruxolitinib In Solid Malignancies (NCT07219576) | University of California, San Diego | 2026-01-08 |
| GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment (NCT07193134) | CHU de Quebec-Universite Laval | 2026-01-07 |
| A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors (NCT07298772) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-01-07 |
| A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults (NCT07473570) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-01-07 |
| A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC) (NCT07229911) | Takeda | 2026-01-07 |
| Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State (NCT07342062) | Dong-A ST Co., Ltd. | 2026-01-06 |
| Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom (NCT07239596) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-01-06 |
| Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers (NCT07349758) | Johns Hopkins University | 2026-01-06 |
| Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies (NCT07284433) | AvenCell Therapeutics, Inc. | 2026-01-06 |
| A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) (NCT07187973) | Disc Medicine, Inc | 2026-01-06 |
| Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1 (NCT07070999) | Gemma Biotherapeutics | 2026-01-06 |
| Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults (NCT07363395) | Alcamena Stem Cell Therapeutics | 2026-01-06 |
| Living Independence Through Functional Training (NCT07125378) | University of Florida | 2026-01-06 |
| A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants (NCT07347548) | Grünenthal GmbH | 2026-01-06 |
| Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine (NCT07400003) | Sinovac Biotech Co., Ltd | 2026-01-06 |
| A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment (NCT07343960) | AstraZeneca | 2026-01-06 |
| An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS) (NCT07361354) | Angitia Incorporated Limited | 2026-01-05 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males (NCT07407543) | siRNAgen Therapeutics Inc. | 2026-01-05 |
| A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses (NCT07280936) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-01-05 |
| Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma (NCT06968988) | Washington University School of Medicine | 2026-01-05 |
| An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants (NCT07357610) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2026-01-05 |
| RCT of Psilocybin-assisted CBT for Depression (NCT07281352) | University of California, Los Angeles | 2026-01-05 |
| A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy (NCT07289477) | iRegene Therapeutics Co., Ltd. | 2026-01-05 |
| A Clinical Trial of P134 Cells in Recurrent Glioblastoma (NCT07318818) | Tasly Pharmaceutical Group Co., Ltd | 2026-01-05 |
| Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC) (NCT07653503) | University Medical Center Groningen | 2026-01-05 |
| Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1 (NCT06517693) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-01-05 |
| Phase I Study of FXS887 in the Treatment of Solid Tumors (NCT07345637) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2026-01-05 |
| Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites (NCT07435701) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-01-05 |
| A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors (NCT07354711) | 3H Pharmaceuticals Co., Ltd. | 2026-01-04 |
| SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a) (NCT07745114) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2026-01-04 |
| Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers (NCT07302269) | Vigonvita Life Sciences | 2026-01-04 |
| AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial (NCT05491681) | BioCardia, Inc. | 2026-01-04 |
| A Study of TJ101 Injection Before and After CMC Change Following Subcutaneous Injection in Healthy Adult Male Subjects in China (NCT07300436) | TJ Biopharma Co., Ltd. | 2026-01-04 |
| KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (NCT07246707) | Zhejiang University | 2026-01-02 |
| A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine) (NCT07335419) | Pfizer | 2026-01-02 |
| Imetelstat Combinations in Relapsed AML (NCT07320235) | Douglas Tremblay | 2026-01-02 |
| Efficacy of Interleukin-2 in Triple Negative Breast Cancer (NCT05821686) | Nova Scotia Health Authority | 2026-01-02 |
| Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML) (NCT07128381) | M.D. Anderson Cancer Center | 2026-01-02 |
| Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT07269639) | Seoul National University Hospital | 2026-01-01 |
| Children of Age 2-6years Undergoing Elective Surgery Will be Divided Into Two Groups Randomly. This Study Aims to Evaluate if Intranasal Dexmedetomidine is Better Than Intranasal Ketamine in Producing Sedation and Reducing Parent Separation Anxiety Before Surgery. (NCT07180095) | Liaquat National Hospital & Medical College | 2026-01-01 |
| DPTX3186 in Wnt Pathway Activated Solid Tumors (NCT07312903) | Dewpoint Therapeutics | 2026-01-01 |
| Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline (NCT07123363) | Wake Forest University Health Sciences | 2026-01-01 |
| A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. (NCT07157033) | Xerient Pharma | 2026-01-01 |
| EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas (NCT07339527) | Sun Yat-sen University | 2026-01-01 |
| Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS) (NCT07173361) | McMaster University | 2026-01-01 |
| Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) (NCT07307053) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-01-01 |
| This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma. (NCT07162571) | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | 2026-01-01 |
| Phase 1 Study of Intravaginal KB15A (NCT07222020) | ZabBio Inc. | 2026-01-01 |
| First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers. (NCT07377253) | Giuseppe Pantaleo | 2026-01-01 |
| Epileptic Hippocampus in Alzheimer's Disease (NCT05899764) | University of California, Los Angeles | 2026-01-01 |
| CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases (NCT07315087) | Institute of Hematology & Blood Diseases Hospital, China | 2026-01-01 |
| Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT07368270) | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | 2026-01-01 |
| A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer (NCT07333573) | Shanghai Zhongshan Hospital | 2026-01-01 |
| KN5501 Cell Injection for Refractory SLE(CLEAR) (NCT07358988) | Ruitherapeutics Co., LTD | 2026-01-01 |
| ADO-5030 in Bronchoconstriction Challenge, Phase 1b (NCT07281274) | Adovate | 2026-01-01 |
| Magnesium Sulfate in Pediatric Burn Dressing Changes (NCT07126795) | Hennepin Healthcare Research Institute | 2026-01-01 |
| The Effect of Daily Supplementation With Humiome® Post LB on Gastrointestinal Symptoms in Female Athletes (NCT07366931) | Liverpool John Moores University | 2026-01-01 |
| Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma (NCT07369492) | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | 2026-01-01 |
| A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults (NCT07313150) | Qilu Pharmaceutical Co., Ltd. | 2026-01-01 |
| NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer (NCT07314385) | National Taiwan University Hospital | 2026-01-01 |
| A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors (NCT06357377) | Neonc Technologies, Inc. | 2026-01-01 |
| A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies (NCT07294300) | Qilu Pharmaceutical Co., Ltd. | 2026-01-01 |
| First in Human Study of QLS5316 in Solid Tumors (NCT07358884) | Qilu Pharmaceutical Co., Ltd. | 2026-01-01 |
| Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia (NCT07575971) | Liping Dou | 2026-01-01 |
| A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer (NCT07287748) | Alpha Fusion Inc. | 2026-01-01 |
| Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer (NCT06462092) | Guangzhou Medical University | 2026-01-01 |
| Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms (NCT07182058) | U: The Mind Company | 2026-01-01 |
| Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Patients Undergoing Radical Mastectomy (NCT07289178) | First Affiliated Hospital of Kunming Medical University | 2026-01-01 |
| A Study to Evaluate the Pharmacokinetics and Safety of IN-M00007 and IN-R00007 in Healthy Adult Volunteers (NCT07311811) | HK inno.N Corporation | 2026-01-01 |
| Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE (NCT07331467) | Chongqing Precision Biotech Co., Ltd | 2026-01-01 |
| Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer (NCT07342725) | Ruijin Hospital | 2026-01-01 |
| Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T (NCT07621692) | National Taiwan University Hospital | 2026-01-01 |
| Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults (NCT07331545) | Qilu Pharmaceutical Co., Ltd. | 2026-01-01 |
| Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject (NCT07117383) | Aspargo Labs, Inc | 2026-01-01 |
| BCMA-CD19 cCAR T for the Treatment of Refractory Lupus (NCT07328581) | iCell Gene Therapeutics | 2026-01-01 |
| 177Lu-CTR-FAPI for the Treatment of Thyroid Cancer (NCT07438847) | SHAOYAN LIU | 2026-01-01 |
| Study of CM383 in Healthy Subjects (NCT07292688) | Keymed Biosciences Co.Ltd | 2026-01-01 |
| Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma (NCT06981806) | Arsen Osipov | 2026-01-01 |
| Study of ACC-1898 in Adult Participants With Advanced Solid Tumors (NCT07252661) | AccSalus Biosciences, Inc. | 2026-01-01 |
| A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer (NCT07349043) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-01-01 |
| Brain State-dependent PCMS in Chronic Stroke (NCT04830163) | University of Texas at Austin | 2026-01-01 |
| Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease (NCT07061938) | Acepodia Biotech, Inc. | 2026-01-01 |
| Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC (NCT07353294) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-01-01 |
| Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain (NCT05575999) | Kansas City Heart Rhythm Research Foundation | 2026-01-01 |
| Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL) (NCT07078929) | Chulalongkorn University | 2026-01-01 |
| Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer (NCT07273396) | Seoul National University Hospital | 2026-01-01 |
| Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors (NCT07282873) | TYK Medicines, Inc | 2026-01-01 |